Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT Cohort.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Modeling Podocytopathies with Kidney Organoids.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Podocyte-derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis.

Kidney international·2026
Same author

<i>Fosl2</i> regulates the transition from parietal epithelial cells to myofibroblasts in the kidney.

bioRxiv : the preprint server for biology·2025
Same author

Design and development of a urinary cell pellet mRNA PCR-based assay for progressive kidney disease: Nephro-Dx.

medRxiv : the preprint server for health sciences·2025
Same author

Liquid Biopsy-Multiomics Link Adhesion Pathway Dysregulation to Kidney Injury Severity.

Kidney international reports·2025

Related Experiment Video

Updated: Jun 26, 2025

Author Spotlight: Generation of Patient-Derived Podocytes from Skin Biopsies
08:52

Author Spotlight: Generation of Patient-Derived Podocytes from Skin Biopsies

Published on: May 26, 2023

2.1K

Podocyte-targeted therapies - progress and future directions.

Kristin Meliambro1, John C He1, Kirk N Campbell2

  • 1Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Nature Reviews. Nephrology
|May 9, 2024
PubMed
Summary
This summary is machine-generated.

Podocyte injury drives proteinuric kidney disorders, leading to kidney failure. Recent advances in understanding podocyte pathogenesis offer hope for new precision therapies beyond current immunosuppressants.

More Related Videos

Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions
08:06

Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions

Published on: July 2, 2020

4.6K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

401

Related Experiment Videos

Last Updated: Jun 26, 2025

Author Spotlight: Generation of Patient-Derived Podocytes from Skin Biopsies
08:52

Author Spotlight: Generation of Patient-Derived Podocytes from Skin Biopsies

Published on: May 26, 2023

2.1K
Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions
08:06

Guided Differentiation of Mature Kidney Podocytes from Human Induced Pluripotent Stem Cells Under Chemically Defined Conditions

Published on: July 2, 2020

4.6K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

401

Area of Science:

  • Nephrology
  • Cell Biology
  • Genetics

Background:

  • Podocytes are crucial cells targeted in proteinuric kidney disorders, a major cause of kidney failure.
  • Established link between podocyte depletion and proteinuria severity in progressive glomerular disease.
  • Current therapies for podocytopathies primarily use repurposed immunosuppressive drugs with limited success.

Purpose of the Study:

  • To review recent advancements in understanding podocyte injury mechanisms.
  • To highlight emerging therapeutic strategies for glomerular diseases.
  • To discuss the potential of precision medicine in treating podocytopathies.

Main Methods:

  • Review of seminal experimental and clinical studies.
  • Analysis of genetic discoveries in podocytopathies.
  • Evaluation of novel therapeutic targets and regenerative approaches.

Main Results:

  • Identification of numerous disease-causing genes and glomerular permeability factors.
  • Progress in understanding the mechanistic basis of podocyte injury.
  • Development of potential regenerative strategies using progenitor cells.

Conclusions:

  • Significant progress in understanding podocyte injury opens avenues for precision therapies.
  • Novel targets, regenerative approaches, and drug delivery systems offer an optimistic future for glomerular disease treatment.
  • Future therapies may move beyond current immunosuppressive regimens.